Intellectual Property India Publishes Patent Application for 'Amino Quinazoline Derivatives As P2x3 Inhibitors' Filed by Chiesi Farmaceutici S. P. A.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202518036013 A) filed by Chiesi Farmaceutici S. P. A., Parma, Italy, on April 14, for 'amino quinazoline derivatives as p2x3 inhibitors.'

Inventor(s) include Bruno, Paolo; Biagetti, Matteo; Fiorelli, Claudio; Pizzirani, Daniela; Pala, Daniele; Ronchi, Paolo; Baker-Glenn, Charles; Van De Poel, Herve; and Hirst, Kim, Louise.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to compounds of formula I inhibiting P2X purinoceptor 3; particularly the invention relates to compounds that are amino quinazoline derivatives, methods...